Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (15 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← Scotland alerts

Scotland · NHS Scotland MSAN

Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes

MSAN(2024)3 · Level 2 · issued 29 Feb 2024

Reference
MSAN(2024)3
Issued
29 Feb 2024
Priority
Level 2
Valid until
TBC as stated by the source
Source
Signed NHS Scotland notice (PDF) ↗

What the notice states

The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.

ProductPositionResupply
of stock. Resupply date of this product is to be confirmed.Resupply date to be confirmed—
remain available and can support increased demand.Available—
Registration for access to the website is available to UK healthcare professionals andAvailable—

Provenance

Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.

scot:msan:2024:3

Recorded
13 Aug 2026 22:03 UTC
Capture route
Captured first-hand by ShortageSignal's scheduled check
Read from
NHS Scotland Medicine Supply Alert Notice (PDF)
Captured at
13 Aug 2026 22:03 UTC
Content hash
5968cc1ede25f766e244847d218351f0c395179e0c702d242f5bbf92891a394d
sha256 of the captured bytes — proves what was captured, not that the source was correct
Source document
https://www.publications.scot.nhs.uk/files/msan-2024-03.pdf ↗

From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.